|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Trevi Therapeutics, Inc. (TRVI) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
101,750,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Trevi Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (nalbuphine ER) to treat neurologically mediated conditions. Co. is developing Haduvio for the treatment of chronic pruritus associated with prurigo nodularis and chronic cough in patients with idiopathic pulmonary fibrosis. These conditions share a common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems. Haduvio is an oral extended-release formulation of nalbuphine. Nalbuphine is a mixed k-opioid receptor agonist and m-opioid receptor antagonist.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
86,576 |
200,312 |
290,510 |
| Total Sell Value |
$0 |
$583,503 |
$921,530 |
$1,160,345 |
| Total People Sold |
0 |
2 |
4 |
5 |
| Total Sell Transactions |
0 |
2 |
12 |
20 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Good Jennifer L |
President & CEO |
• • – |
2025-03-21 |
4 |
S |
$6.58 |
$34,625 |
D/D |
(5,263) |
213,313 |
|
- |
|
| Good Jennifer L |
President & CEO |
• • – |
2025-03-21 |
4 |
OE |
$1.43 |
$7,526 |
D/D |
5,263 |
218,576 |
|
- |
|
| Simon Farrell |
Chief Commercial Officer |
• – – |
2025-03-10 |
4 |
AS |
$6.73 |
$548,878 |
D/D |
(81,313) |
76,900 |
|
- |
|
| Simon Farrell |
Chief Commercial Officer |
• – – |
2025-03-10 |
4 |
OE |
$0.51 |
$321,653 |
D/D |
112,563 |
158,213 |
|
- |
|
| Delfini Lisa |
Chief Financial Officer |
• – – |
2025-01-08 |
4 |
OE |
$0.51 |
$2,555 |
D/D |
5,000 |
64,660 |
|
- |
|
| Delfini Lisa |
Chief Financial Officer |
• – – |
2025-01-07 |
4 |
OE |
$0.51 |
$511 |
D/D |
1,000 |
59,660 |
|
- |
|
| Galletta Christopher |
See Remarks |
• – – |
2024-12-13 |
4 |
OE |
$0.51 |
$7,665 |
D/D |
15,000 |
19,935 |
|
- |
|
| Good Jennifer L |
President & CEO |
• • – |
2024-09-09 |
4 |
S |
$3.04 |
$5,587 |
D/D |
(1,840) |
213,313 |
|
- |
|
| Good Jennifer L |
President & CEO |
• • – |
2024-09-09 |
4 |
OE |
$1.43 |
$2,631 |
D/D |
1,840 |
215,153 |
|
- |
|
| Good Jennifer L |
President & CEO |
• • – |
2024-09-06 |
4 |
S |
$3.03 |
$12,784 |
D/D |
(4,219) |
213,313 |
|
- |
|
| Good Jennifer L |
President & CEO |
• • – |
2024-09-06 |
4 |
OE |
$1.43 |
$6,033 |
D/D |
4,219 |
217,532 |
|
- |
|
| Good Jennifer L |
President & CEO |
• • – |
2024-09-05 |
4 |
S |
$3.11 |
$125,310 |
D/D |
(40,277) |
213,313 |
|
- |
|
| Good Jennifer L |
President & CEO |
• • – |
2024-09-05 |
4 |
OE |
$1.43 |
$57,596 |
D/D |
40,277 |
253,590 |
|
- |
|
| Good Jennifer L |
President & CEO |
• • – |
2024-09-04 |
4 |
S |
$3.02 |
$33,205 |
D/D |
(10,981) |
213,313 |
|
- |
|
| Good Jennifer L |
President & CEO |
• • – |
2024-09-04 |
4 |
OE |
$1.43 |
$15,703 |
D/D |
10,981 |
224,294 |
|
- |
|
| Good Jennifer L |
President & CEO |
• • – |
2024-09-03 |
4 |
S |
$3.02 |
$11,677 |
D/D |
(3,863) |
213,313 |
|
- |
|
| Good Jennifer L |
President & CEO |
• • – |
2024-09-03 |
4 |
OE |
$1.43 |
$5,524 |
D/D |
3,863 |
217,176 |
|
- |
|
| Meeker David P |
|
– • – |
2024-08-27 |
4 |
S |
$2.93 |
$13,353 |
D/D |
(4,555) |
352,489 |
|
- |
|
| Meeker David P |
|
– • – |
2024-08-27 |
4 |
OE |
$1.43 |
$6,514 |
D/D |
4,555 |
357,044 |
|
- |
|
| Sciascia Thomas |
Chief Scientific Officer |
• – – |
2024-08-19 |
4 |
S |
$2.96 |
$48,883 |
D/D |
(16,496) |
220,315 |
|
- |
|
| Sciascia Thomas |
Chief Scientific Officer |
• – – |
2024-08-19 |
4 |
OE |
$1.43 |
$23,589 |
D/D |
16,496 |
236,811 |
|
- |
|
| Sciascia Thomas |
Chief Scientific Officer |
• – – |
2024-08-16 |
4 |
S |
$2.76 |
$51,440 |
D/D |
(18,660) |
220,315 |
|
- |
|
| Sciascia Thomas |
Chief Scientific Officer |
• – – |
2024-08-16 |
4 |
OE |
$1.43 |
$26,684 |
D/D |
18,660 |
238,975 |
|
- |
|
| Sciascia Thomas |
Chief Scientific Officer |
• – – |
2024-08-15 |
4 |
S |
$2.79 |
$35,513 |
D/D |
(12,745) |
220,315 |
|
- |
|
| Sciascia Thomas |
Chief Scientific Officer |
• – – |
2024-08-15 |
4 |
OE |
$1.43 |
$18,225 |
D/D |
12,745 |
233,060 |
|
- |
|
163 Records found
|
|
Page 1 of 7 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
